GGrantIndex
Sort

21,453 grants matching tuberculosis

The mechanistic enzymology of thiamin biosynthesis

$340,832
Tadhg P. Begley · Texas A&M University · R37 · FY2010 · DK

Inflammatory and immune dysregulation associated lung disease

$340,762
Kenneth Olivier · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

HTS for bactericidal inhibitors of M. tuberculosis copper resistance mechanisms

$340,718
Frank Wolschendorf · University Of Alabama At Birmingham · R01 · FY2013 · AI

MYCOBACTERIUM TUBERCULOSIS REPLICATION AND PROLIFERATION

$340,610
Murty V. Madiraju · University Of Texas Hlth Ctr At Tyler · R01 · FY2009 · AI

Animal Models Core

$340,541
Soumya Raychaudhuri · Brigham And Women'S Hospital · U19 · FY2016 · AI

Manipulation of Host Innate Immunity by Listeria

$340,474
Daniel A Portnoy · University Of California Berkeley · P01 · FY2007 · AI

TUBERCULOSIS CONTROL PROGRAM AND AIDS

$340,454
Loretta Emily Haddy · West Virginia State Dept Hlth/Human Rscs · U52 · FY2007 · PS

TB and Innate Immune Regulation of Lung Macrophages

$340,439
Larry S. Schlesinger · Ohio State University · R01 · FY2012 · AI

Pathogenesis of Infectious Diseases Training Program

$340,426
Warren D. Johnson · Weill Medical Coll Of Cornell Univ · T32 · FY2010 · AI

Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)

$340,382
Graeme Ayton Meintjes · University Of Cape Town · R01 · FY2021 · AI

Principles of Protein Mimicry of DNA

$340,300
Michael D Brenowitz · Albert Einstein College Of Medicine · R01 · FY2008 · GM

Structural studies of RNA polymerase regulation by RNA

$340,239
Seth A Darst · Rockefeller University · R01 · FY2012 · GM

Checkpoints of TNF Gene Regulation

$340,229
Anne Goldfeld · Immune Disease Institute, Inc. · R01 · FY2008 · GM

Checkpoints of TNF Gene Regulation

$340,229
Anne Goldfeld · Immune Disease Institute, Inc. · R01 · FY2007 · GM

Structure and Function of Response Regulator Proteins

$340,087
Ann M. Stock · Univ Of Med/Dent Nj-R W Johnson Med Sch · R37 · FY2010 · GM

CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS

$340,053
Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2017 · OD

Pressurized Metered Dose Inhaler Formulations for the Pulmonary Delivery of Nanotherapeutics to and through the Lungs

$339,999
Sandro R Da Rocha · Wayne State University · · FY2009 · ENG

Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes

$339,935
David R Sherman · Rutgers Biomedical And Health Sciences · U19 · FY2023 · AI

Bacterial and Host Heterogeneity in TB latency, persistence and progression

$339,935
David Alland · Rutgers Biomedical And Health Sciences · U19 · FY2023 · AI

Research Training in Lung Disease

$339,880
Tony Eissa · Baylor College Of Medicine · T32 · FY2010 · HL

Membrane Interaction of Mycobacterium tuberculosis Virulence Factors

$339,750
Jianjun Sun · University Of Texas El Paso · SC1 · FY2017 · GM

Membrane Interaction of Mycobacterium tuberculosis Virulence Factors

$339,750
Jianjun Sun · University Of Texas El Paso · SC1 · FY2018 · GM

Membrane Interaction of Mycobacterium tuberculosis Virulence Factors

$339,750
Jianjun Sun · University Of Texas El Paso · SC1 · FY2019 · GM

Role of Cholesterol Metabolism in Pathogenesis of Mycobacterium Tuberculosis

$339,750
Hugues Ouellet · University Of Texas El Paso · SC1 · FY2016 · AI

Design of Antituberculosis Agents that Target Siderophore Biosynthesis

$339,750
Courtney C Aldrich · University Of Minnesota · R01 · FY2010 · AI